CellAction
Company

CellAction

Research Services 7 employees
Employees
7
Contacts
2
Emails
2

CellAction Overview

Industry
Research Services
Employees
7
Founded
2024
NAICS
Scientific Research and Development Services
Research and Development in the Physical, Engineering, and Life Sciences
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

About CellAction

CellAction (Cell therapy Acceleration and Innovation) is the cell and gene therapy platform of the Paris-Saclay Cancer Cluster (PSCC) at Institut Curie. A first in France, CellAction enables collaborative projects to be launched with industrial partners on a national and international scale. The aim is to accelerate the development of optimized cell and gene therapies. CellAction is founded on the centralization of key expertise required for the drug development process: - Institut Curie's highly qualified medical-scientific teams - Cutting-edge technologies for in vitro and in vivo testing - Experienced advisors on business development and processes. This integrated structure makes it possible to launch projects for the development of innovative cell and gene therapies, from basic research through to their transfer to the clinic and delivery to patients.

CellAction Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage

CellAction Org Chart

Sample employees and titles
Name Title Contact
Kyle Raymond Scientist in Cell and Gene Therapy
Email
Daniel De Murat Bioinformaticien
View
Lamia Lamrani Ingénieure De Recherche
View
Lisseth Silva Scientist Pursuing New Opportunities
Email

Employees by Management Level

Individual contributor 4 profiles

CellAction Tech Stack

Data / AI 2 profiles

Compare Similar Companies to CellAction